Hepatocellular carcinoma (HCC) is the most common type of liver cancer and one of the
leading causes of cancer-related death worldwide. Advanced HCC displays strong …

Platinum-based anticancer drugs occupy a crucial role in the treatment of various malignant
tumours. However, the efficacy and applicability of platinum drugs are heavily restricted by …

Nanoparticles possess enormous potential as diagnostic imaging agents and hold promise
for the development of multimodality agents with both imaging and therapeutic capabilities …

The paradigm of using nanoparticulate pharmaceutical carriers has been well established
over the past decade, both in pharmaceutical research and in the clinical setting. Drug …

Introduction There is emerging interest in medicinal plants in the biomedical field, due to
their multitude of chemicals which show anti-inflammatory, antimicrobial, antiviral, or …

Two major obstacles facing cancer nanomedicine are the tendency of nanoparticles to be
taken up by normal tissues and organs and the nanoparticles' inability to efficiently penetrate …

Nanoparticles as drug delivery systems enable unique approaches for cancer treatment.
Over the last two decades, a large number of nanoparticle delivery systems have been …

The design of novel drug delivery systems is exceptionally critical in disease treatments.
Among the existing drug delivery systems, mesoporous silica nanoparticles (MSNs) have …

Degenerative diseases are results of deterioration of cells and tissues with aging either by
unhealthy lifestyle or normal senescence. The degenerative disease likely affects central …

Temporarily implanted devices, such as drug-loaded contact lenses, are emerging as the
preferred treatment method for ocular diseases like glaucoma. Localizing the delivery of …